3-methanesulfonylquinolines as GABAB enhancers
US7728142B2 · kind B2 · utility
0Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2006 |
| Grant date | Jun 1, 2010 |
| Priority date | — |
| Expiry date | Apr 1, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula Iwherein R1, R2 and R3 are as defined in the specification, which are active at the GABAB receptor and which can be used for the treatment of CNS disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.